contact – epilipidnet

Contact & Join

We want to expand the Epilipidnet network and welcome new members.

If you are from a European country not currently represented on our Management Committee, please contact your Country’s National Coordinators (CNC). You can find their details here.

How to join

To be part of the Action you have to join one or more of our Working Groups (WG). Please choose the WG, fill out the template form (don’t forget to add your name to the filename when you save the Word file) and sent it to the relevant WG Leader for evaluation (fill in a template for each WG you want to join).

WG 1 – Harmonization of lipidomics workflows to increase natural lipidome coverage
Leader: Dr Justine BERTRAND-MICHEL – Justine.Bertrand-michel@inserm.fr
WG 2 – Epilipidomics analysis and data integration strategies
Leader: Dr Laura GORACCI – laura.goracci@unipg.it
WG 3 – Clinical significance and applications of (epi)lipidomics
Leader: Prof Matej ORESIC – matej.oresic@oru.se
WG 4 – Integration of (epi)lipidomics with Lipid signalling and mechanisms of action
Leader: Dr Florian GRUBER – florian.gruber@meduniwien.ac.at
WG 5 – Dissemination and outreach
Leader: Prof Corinne SPICKETT – c.m.spickett@aston.ac.uk

Contacts

If you have specific questions about COST, please contact the COST Officers:

Administrative officer | Ms Svetlana VOINOVA
+3225333848 | svetlana.voinova@cost.eu

Science officer | Dr Lucia FORZI
+3225333858 | lucia.forzi@cost.eu

For other types of enquires please contact the Action Chair or the Deputy Chair:

Action Chair | Prof Maria Do Rosário DOMINGUES
Phone: 00 351 234 370 698
Email: mrd@ua.pt

Deputy Chair | Dr Maria FEDOROVA
maria.fedorova@bbz.uni-leipzig.de

Further contacts available here.

CA19105 – Pan-European Network in Lipidomics and EpiLipidomics

CSO Approval Date: 24 March 2020
Start Date: 13 October 2020
End Date: 12 October 2024
EpiLipidNET aims to build and maintain a multidisciplinary pan-European network of researchers, clinicians and enterprises working in the field of lipidomics and epilipidomics to boost a hub of research excellence, advanced knowledge and technology transfer, to promote high level of training for young researches and facilitate clinical translation.